Kyle S. Knox

Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial

F. Markowetz, T. Bray, Shruti Singh, 2020, The Lancet.

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Nigel de Kare-Silver, S. Royal, K. Hood, 2022, The Lancet.

Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial

Karim Ladha, Richard Baskerville, Ruth Osborne, 2018, The Lancet.

Space Launch System Base Heating Test: Environments and Base Flow Physics

Manish Mehta, C. Mark Seaford, Aaron Dufrene, 2016 .

Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial

F. Markowetz, T. Bray, L. Lovat, 2020, The Lancet.